BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 16633107)

  • 1. The effects of treatment with octreotide, diuretics, or both on portal hemodynamics in nonazotemic cirrhotic patients with ascites.
    Kalambokis G; Economou M; Kosta P; Papadimitriou K; Tsianos EV
    J Clin Gastroenterol; 2006 Apr; 40(4):342-6. PubMed ID: 16633107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal effects of treatment with diuretics, octreotide or both, in non-azotemic cirrhotic patients with ascites.
    Kalambokis G; Economou M; Fotopoulos A; Bokharhii JA; Katsaraki A; Tsianos EV
    Nephrol Dial Transplant; 2005 Aug; 20(8):1623-9. PubMed ID: 15886218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive factors influencing the therapeutic response to diuretic treatment of ascites in nonazotemic cirrhotic patients.
    Ljubicić N; Kujundzić M; Banić M; Vrkljan M
    Scand J Gastroenterol; 1998 Apr; 33(4):441-7. PubMed ID: 9605268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized comparative study of efficacy of furosemide versus spironolactone in nonazotemic cirrhosis with ascites. Relationship between the diuretic response and the activity of the renin-aldosterone system.
    Pérez-Ayuso RM; Arroyo V; Planas R; Gaya J; Bory F; Rimola A; Rivera F; Rodés J
    Gastroenterology; 1983 May; 84(5 Pt 1):961-8. PubMed ID: 6339312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of subcutaneous administration of octreotide on endogenous vasoactive systems and renal function in cirrhotic patients with ascites.
    Sàbat M; Guarner C; Soriano G; Bulbena O; Novella MT; Ortiz J; Ricart E; Villanueva C; Rosello J; Rodríguez J; Balanzó J
    Dig Dis Sci; 1998 Oct; 43(10):2184-9. PubMed ID: 9790452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of chronic treatment with octreotide versus octreotide plus midodrine on systemic hemodynamics and renal hemodynamics and function in nonazotemic cirrhotic patients with ascites.
    Kalambokis G; Economou M; Fotopoulos A; Al Bokharhii J; Pappas C; Katsaraki A; Tsianos EV
    Am J Gastroenterol; 2005 Apr; 100(4):879-85. PubMed ID: 15784036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A pathophysiological interpretation of unresponsiveness to spironolactone in a stepped-care approach to the diuretic treatment of ascites in nonazotemic cirrhotic patients.
    Gatta A; Angeli P; Caregaro L; Menon F; Sacerdoti D; Merkel C
    Hepatology; 1991 Aug; 14(2):231-6. PubMed ID: 1860680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Biological factors influencing response to diuretics in patients with cirrhosis and ascites].
    Lenaerts A; Codden T; Henry JP; Van Cauter J; Meunier JC; Ligny G
    Gastroenterol Clin Biol; 2001 Mar; 25(3):268-72. PubMed ID: 11395674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of clonidine on diuretic response in ascitic patients with cirrhosis and activation of sympathetic nervous system.
    Lenaerts A; Codden T; Meunier JC; Henry JP; Ligny G
    Hepatology; 2006 Oct; 44(4):844-9. PubMed ID: 17006921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of captopril on renal functions, renal and portal hemodynamics in patients with cirrhosis.
    Tsai YT; Lin HC; Lee FY; Hou MC; Wang SS; Lee SD
    Proc Natl Sci Counc Repub China B; 1996 Apr; 20(2):44-50. PubMed ID: 8931343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The effects of octreotide on portal hemodynamics in patients with liver cirrhosis].
    Zhu Q; Jiang XH; Yi F; Jiang Y; Sun YW; Yuan YZ; Wu YL
    Zhonghua Nei Ke Za Zhi; 2004 Jan; 43(1):16-8. PubMed ID: 14990014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interest of the association clonidine-spironolactone in cirrhotic patients with ascites and activation of sympathetic nervous system.
    Lenaerts A; Codden T; Van Cauter J; Meunier JC; Henry JP; Ligny G
    Acta Gastroenterol Belg; 2002; 65(1):1-5. PubMed ID: 12014310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interrelationships between systemic hemodynamics, urinary sodium excretion, and renin-angiotensin system in cirrhosis.
    Aliaga L; Zozoya JM; Omar M; Mediavilla JD; Prieto J
    Acta Gastroenterol Belg; 1995; 58(2):213-21. PubMed ID: 7571982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of diuretic non-responders with poor long-term clinical outcomes: a 1-year follow-up of 176 non-azotaemic cirrhotic patients with moderate ascites.
    Yang YY; Lin HC; Lin MW; Chu CJ; Lee FY; Hou MC; Lee SD; Lee WP; Liu TT; Jap TS
    Clin Sci (Lond); 2011 Dec; 121(11):509-21. PubMed ID: 21692745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diuretic requirements after therapeutic paracentesis in non-azotemic patients with cirrhosis. A randomized double-blind trial of spironolactone versus placebo.
    Fernández-Esparrach G; Guevara M; Sort P; Pardo A; Jiménez W; Ginès P; Planas R; Lebrec D; Geuvel A; Elewaut A; Adler M; Arroyo V
    J Hepatol; 1997 Mar; 26(3):614-20. PubMed ID: 9075669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nadolol plus spironolactone in the prophylaxis of first variceal bleed in nonascitic cirrhotic patients: A preliminary study.
    Abecasis R; Kravetz D; Fassio E; Ameigeiras B; Garcia D; Isla R; Landeira G; Dominguez N; Romero G; Argonz J; Terg R
    Hepatology; 2003 Feb; 37(2):359-65. PubMed ID: 12540786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic effects of diuretics and paracentesis on lung function in patients with non-alcoholic cirrhosis and tense ascites.
    Chang SC; Chang HI; Chen FJ; Shiao GM; Wang SS; Lee SD
    J Hepatol; 1997 Apr; 26(4):833-8. PubMed ID: 9126796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuous prazosin administration in cirrhotic patients: effects on portal hemodynamics and on liver and renal function.
    Albillos A; Lledó JL; Rossi I; Pérez-Páramo M; Tabuenca MJ; Bañares R; Iborra J; Garrido A; Escartín P; Bosch J
    Gastroenterology; 1995 Oct; 109(4):1257-65. PubMed ID: 7557093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of piretanide, a new loop diuretic, in cirrhosis with ascites: relationship between the diuretic response and the plasma aldosterone level.
    Arroyo V; Bosch J; Casamitjana R; Cabrera J; Rivera F; Rodés J
    Gut; 1980 Oct; 21(10):855-9. PubMed ID: 7439805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver cirrhosis with ascites: pathogenesis of resistance to diuretics and long-term efficacy and safety of torasemide.
    Knauf H; Mutschler E
    Cardiology; 1994; 84 Suppl 2():87-98. PubMed ID: 7954550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.